- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02569424
Effect of PEEP and Trendelenburg on Ultrasound Size of Internal Jugular and Subclavian Veins (PEEPUS)
Effect of PEEP and Trendelenburg on Ultrasound Size of Internal Jugular and Subclavian Veins: A Cross-over Randomized Controlled Study
There is no recommendation for the management of the positive end-expiratory pressure (PEEP) during setting of a central venous catheter (CVC) in a ventilated patient. Several non-randomized studies have investigated the cross-sectional area (AST) ultrasound minor axis for different pressure levels by evaluating a single vessel every time or by not displaying the right or left side in the evaluation. Another study showed that there could be unpredictable size differences between the 2 subclavian veins.
In ventilated patient, the PEEP, which is intrathoracic, will result in a decrease of venous return and thus possibly a superior vena cava dilation, located outside the pleura, depending on their capacitance. Different pressure levels showed an increase of AST with the increase of intra-thoracic pressure on certain veins, in a heterogeneous and not randomized manner.
The primary purpose of the study is to measure the effect of PEEP (0, 5, 10 or 15 cm H2O) and the patient's position (supine or Trendelenburg strict -15-20 °) on the cross-sectional area of the jugular and subclavian veins.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
There is no recommendation for the management of the positive end-expiratory pressure (PEEP) during setting of a central venous catheter (CVC) in a ventilated patient. Several non-randomized studies have investigated the cross-sectional area (AST) ultrasound minor axis for different pressure levels by evaluating a single vessel every time or by not displaying the right or left side in the evaluation. Another study showed that there could be unpredictable size differences between the 2 subclavian veins.
In ventilated patient, the PEEP, which is intrathoracic, will result in a decrease of venous return and thus possibly a superior vena cava dilation, located outside the pleura, depending on their capacitance. Different pressure levels showed an increase of AST with the increase of intra-thoracic pressure on certain veins, in a heterogeneous and not randomized manner.
The primary purpose of the study is to measure the effect of PEEP (0, 5, 10 or 15 cm H2O) and the patient's position (supine or Trendelenburg strict -15-20 °) on the cross-sectional area of the jugular and subclavian veins.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Clermont-Ferrand, France, 63003
- Chu Clermont-Ferrand
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Any patient ventilated in intensive care is eligible.
- Age ≥ 18 years
- Patient with stable hemodynamic status and Mean Blood Pressure (< 65 mmHg)
- Patient with registered social security number
Exclusion Criteria:
- clinical sign for a central venous thrombosis (unilateral edema ...).during echography screening before inclusion
- presence of a central line for more than 48 hours.
- Anechoic patient (checked during echography screening)
- History of cervical spine surgery.
- IntraCranial HyperTension
- patient in shock with hemodynamic instability and not stabilized
- patient treated by noradrenaline > 1 µg/kg/min
- patient or relative's refusal
- protected patients ≥ 18 years, minors, pregnant women
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ventilated patients
Patient's position (Supine or Trendelenburg strict -20°)
|
Supine or Trendelenburg strict -20°)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The cross-sectional area of the jugular veins ( in cm2)
Time Frame: at baseline
|
The cross-sectional area of the jugular veins ( in cm2) at the end of the intervention
|
at baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The cross-sectional area of the subclavian veins ( in cm2)
Time Frame: at baseline
|
The cross-sectional area of the subclavian veins ( in cm2) at the end of the intervention
|
at baseline
|
The antero-posterior diameter of the jugular veins (in mm)
Time Frame: at baseline
|
The antero-posterior diameter of the jugular veins (in mm) at the end of the intervention
|
at baseline
|
The antero-posterior diameter of the subclavian veins (in mm)
Time Frame: at baseline
|
The antero-posterior diameter of the subclavian veins (in mm) at the end of the intervention
|
at baseline
|
The distance between posterior and pleural lining of the jugular veins (in mm)
Time Frame: at baseline
|
The distance between posterior and pleural lining of the jugular veins (in mm) at the end of the intervention
|
at baseline
|
The distance between posterior and pleural lining of the subclavian veins (in mm)
Time Frame: at baseline
|
The distance between posterior and pleural lining of the subclavian veins (in mm) at the end of the intervention
|
at baseline
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CHU-0246
- 2015-A00606-43 (Registry Identifier: 2015-A00606-43)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventilated Patient in Intensive Care
-
Centre Hospitalier Universitaire DijonCompletedIntubated-ventilated Patients in the Intensive Care UnitFrance
-
Rennes University HospitalCompletedPatient Hospitalized in Intensive Care UnitFrance
-
Centre Hospitalier Intercommunal de Toulon La Seyne...CompletedIntensive Care Patients Invasively VentilatedFrance, Italy
-
Bayside HealthCompletedMechanically Ventilated Patients | Intensive Care | Sedated PatientsAustralia
-
Norwegian University of Science and TechnologyRecruitingIntensive Care PatientNorway
-
Australian and New Zealand Intensive Care Research...Intensive Care Foundation, AustraliaCompletedCritically Ill Adults Ventilated >24 Hours in Intensive CareAustralia, New Zealand
-
Centre Hospitalier Universitaire DijonTerminatedInsertion of a Nasogastric Tube | Intubated Patient | Patients Hospitalized in the Surgery Intensive Care UnitFrance
-
Assistance Publique - Hôpitaux de ParisCompletedPatients Died in Intensive Care Unit (ICU)France
-
University of PennsylvaniaNational Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health...Enrolling by invitationCommunication | Patient Safety | Intensive Care Units | Patient Handoff | Healthcare TeamUnited States
-
University of PennsylvaniaAnesthesia Patient Safety FoundationCompletedCommunication | Patient Safety | Intensive Care Units | Patient Handoff | Healthcare TeamUnited States
Clinical Trials on Patient's position
-
Seoul National University Bundang HospitalUnknownHeart FailureKorea, Republic of
-
M.D. Anderson Cancer CenterActive, not recruitingSexual DysfunctionUnited States
-
University Hospital, Clermont-FerrandCompleted
-
Ain Shams UniversityBenha University; Misr University for Science and Technology; Kuwait Cancer Control... and other collaboratorsUnknown
-
Centre Hospitalier Universitaire de NiceCompletedCognitive DeteriorationFrance
-
University Hospital, MontpellierUnknownCurrent Major Depressive DisorderFrance
-
Stanford UniversityThrasher Research FundCompletedEsophageal AtresiaUnited States
-
Çanakkale Onsekiz Mart UniversityCompletedPosition | Comfort | Newborn, Infant, Disease | ResidualTurkey
-
University Hospital, MontpellierUnknownGeriatrics | Clinical PharmacyFrance
-
Assistance Publique Hopitaux De MarseilleUnknownPsychiatric DisordersFrance